Insulin-like Growth Factors (IGF) Axis (IGFs, Its Binding Proteins,Receptors), Transforming Growth Factor Alpha and Beta 1 and Epidermal Growth Factor in the Urine and Serum of Patients With Hepatocellular Carcinoma.
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Hepatocellular Carcinoma
Both
Hepatocellular Carcinoma
Trial Information
Insulin-like Growth Factors (IGF) Axis (IGFs, Its Binding Proteins,Receptors), Transforming Growth Factor Alpha and Beta 1 and Epidermal Growth Factor in the Urine and Serum of Patients With Hepatocellular Carcinoma.
The clinical relevance of patients will be evaluated by the concentrations of tumor growth
factors.
Inclusion Criteria:
- Histology proven HCC
Exclusion Criteria:
- No definitely diagnosed tumor
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Cross-Sectional
Outcome Measure:
mortality
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Jung-Fa Tsai, M.D., Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Professor of Medine, Kaohsiung Medical University
Authority:
Taiwan: Department of Health
Study ID:
KMUH-IRB-960010
NCT ID:
NCT00764140
Start Date:
January 2007
Completion Date:
April 2010
Related Keywords:
- Hepatocellular Carcinoma
- tumor growth factor
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
